SG-3-0020

N/A

Report date: 2023/03/19 13:26:36

NME

Base Information

Drug NameSG-3-0020

Drug Alias NameSG30020

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSecond Genome Inc

China Registration ClassN/A

Develop Information

Active CompaniesSecond Genome Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A